Get started
Author

Matteo Zampini

Observed names: M Zampini, M. Zampini, Zampini, Matteo
Observed institutions: Humanitas University, University of Padua, Ministero della Salute, Istituti di Ricovero e Cura a Carattere Scientifico, IRCCS Humanitas Research Hospital, Città della Speranza Foundation
ORCID: 0000-0002-9952-1142
Observed ORCID: 0000-0002-9952-1142
OpenAlex ID: A5023988609
Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes
2021 · Matteo Bersanelli, Erica Travaglino, et al. · Journal of Clinical Oncology · 222
PDF
miR148b is a major coordinator of breast cancer progression in a relapse‐associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS, and CSF1
2012 · Daniela Cimino, Cristiano De Pittà, et al. · The FASEB Journal · 152
The lncRNA CASC15 regulates SOX4 expression in RUNX1-rearranged acute leukemia
2017 · Thilini R. Fernando, Jorge R. Contreras, et al. · Molecular Cancer · 137
PDF
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes
2023 · Elisabetta Sauta, Marie Robin, et al. · Journal of Clinical Oncology · 122
PDF
Synthetic Data Generation by Artificial Intelligence to Accelerate Research and Precision Medicine in Hematology
2023 · Saverio D'Amico, Daniele Dall’Olio, et al. · JCO Clinical Cancer Informatics · 96
PDF
Clinical relevance of clonal hematopoiesis in persons aged ≥80 years
2021 · Marianna Rossi, Manja Meggendorfer, et al. · Blood · 70
PDF
NUP98-fusion transcripts characterize different biological entities within acute myeloid leukemia: a report from the AIEOP-AML group
2016 · V Bisio, M Zampini, et al. · Leukemia · 59
PDF
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes
2024 · Cristina Astrid Tentori, Caterina Gregorio, et al. · Journal of Clinical Oncology · 48
Characterization of children with FLT3-ITD acute myeloid leukemia: a report from the AIEOP AML-2002 study group
2016 · E Manara, G Basso, et al. · Leukemia · 40
The Genetics of Myelodysplastic Syndromes: Clinical Relevance
2021 · Chiara Chiereghin, Erica Travaglino, et al. · Genes · 36
PDF
A sex-informed approach to improve the personalised decision making process in myelodysplastic syndromes: a multicentre, observational cohort study
2022 · Giulia Maggioni, Matteo Bersanelli, et al. · The Lancet Haematology · 34
CREB engages C/EBPδ to initiate leukemogenesis
2016 · C Tregnago, E Manara, et al. · Leukemia · 33
PDF
MicroRNA-27a Contributes to Rhabdomyosarcoma Cell Proliferation by Suppressing RARA and RXRA
2015 · Lucia Tombolan, Matteo Zampini, et al. · PLoS ONE · 26
PDF
Epigenetic heterogeneity affects the risk of relapse in children with t(8;21)RUNX1-RUNX1T1-rearranged AML
2018 · Matteo Zampini, Claudia Tregnago, et al. · Leukemia · 23
Characterization and Clinical Implications of p53 Dysfunction in Patients With Myelodysplastic Syndromes
2025 · Matteo Zampini, Elena Riva, et al. · Journal of Clinical Oncology · 20
A three‐mi RNA ‐based expression signature at diagnosis can predict occurrence of relapse in children with t(8;21) RUNX 1‐ RUNX 1T1 acute myeloid leukaemia
2017 · Matteo Zampini, Valeria Bisio, et al. · British Journal of Haematology · 10
An Artificial Intelligence-Based Federated Learning Platform to Boost Precision Medicine in Rare Hematological Diseases: An Initiative By GenoMed4all and Synthema Consortia
2024 · Gianluca Asti, Saverio D'Amico, et al. · Blood · 8
PDF
Molecular-Based Ecosystem to Improve Personalized Medicine in Chronic Myelomonocytic Leukemia
2026 · Luca Lanino, Anthony M. Hunter, et al. · Journal of Clinical Oncology · 5
A Comprehensive, Artificial Intelligence, Digital Twin Platform Based on Multimodal Real-World Data Integration for Personalized Medicine in Hematology
2024 · Saverio D'Amico, Elisabetta Sauta, et al. · Blood · 5
PDF
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Myelodysplastic Syndromes (MDS)
2023 · Cristina Astrid Tentori, Caterina Gregorio, et al. · Blood · 5
PU.1-activated genomic regions define low-risk MDS subsets characterized by immune dysregulation and disease progression
2026 · Veronica Vallelonga, Francesco Gandolfi, et al. · Blood · 4
PDF
Clinical Text Reports to Stratify Patients Affected with Myeloid Neoplasms Using Natural Language Processing
2023 · Gianluca Asti, Elisabetta Sauta, et al. · Blood · 4
Real-World Validation of Molecular International Prognostic Scoring System (IPSS-M) for Myelodysplastic Syndromes
2022 · Elisabetta Sauta, Marie Robin, et al. · Blood · 4
Long Non Coding RNA BALR2-CDK6 Axis Influences Cell Differentiation and Metabolic Status of Acute Myeloid Leukemia
2017 · Valéria Bisio, Claudia Tregnago, et al. · Blood · 4
A Molecular-Based Ecosystem to Improve Personalized Medicine in Patients with Chronic Myelomonocytic Leukemia (CMML)
2024 · Luca Lanino, Anthony M. Hunter, et al. · Blood · 3
PDF
Works count: 72
Citation count: 1,197
H-index: 15
I10-index: 16
Year
Topic
Type